Based on multivariate analysis, TMEM60 could be considered an independent risk factor for the prognosis of glioma patients based on CGGA RNA-seq (Figure 3D; HR = 1.328, 95% CI = 1.159–1.522, p < .001) and TGGA RNA-array (Figure 3F; HR = 1.790, 95% CI = 1.179–2.718, p < .01) but not based on TGGA RNA-seq (Figure 3B; HR = 1.321, 95% CI = .935–1.868, NS). Here, TMEM60 is linked to central nervous system cancer.